Timeline

Our go-to-market strategy

Lorem ipsum dolor sit amet.

2020 Q1
2020 Q1
2020 Q1
2020 Q1
2020 Q1
Trial preparations
Trial preparations
Trial preparations
Trial preparations
Trial preparations
Q2
Q2
Q2
Q2
Q2
Protocol development
Protocol development
Protocol development
Protocol development
Protocol development
TLA-002 Trial start
TLA-002 Trial start
TLA-002 Trial start
TLA-002 Trial start
TLA-002 Trial start
CRO selection
CRO selection
CRO selection
CRO selection
CRO selection
CCR2 R&D
CCR2 R&D
CCR2 R&D
CCR2 R&D
CCR2 R&D
Q3
Q3
Q3
Q3
Q3
FDA PMA meeting
FDA PMA meeting
FDA PMA meeting
FDA PMA meeting
FDA PMA meeting
Site selection
Site selection
Site selection
Site selection
Site selection
Q4
Q4
Q4
Q4
Q4
Regulatory processing
Regulatory processing
Regulatory processing
Regulatory processing
Regulatory processing
2021 Q1
2021 Q1
2021 Q1
2021 Q1
2021 Q1
TLA-003 Trial start
TLA-003 Trial start
TLA-003 Trial start
TLA-003 Trial start
TLA-003 Trial start
TLA-004 Trial start (Bouquet/pediatric IBD)
TLA-004 Trial start (Bouquet/pediatric IBD)
TLA-004 Trial start (Bouquet/pediatric IBD)
TLA-004 Trial start (Bouquet/pediatric IBD)
TLA-004 Trial start (Bouquet/pediatric IBD)
Manufacturing process development
Manufacturing process development
Manufacturing process development
Manufacturing process development
Manufacturing process development
Q2
Q2
Q2
Q2
Q2
TLA-002 Study report finalized
TLA-002 Study report finalized
TLA-002 Study report finalized
TLA-002 Study report finalized
TLA-002 Study report finalized
TLA-002 Trial end
TLA-002 Trial end
TLA-002 Trial end
TLA-002 Trial end
TLA-002 Trial end
Q3
Q3
Q3
Q3
Q3
Device production and trial preparations
Device production and trial preparations
Device production and trial preparations
Device production and trial preparations
Device production and trial preparations
Device manufacturing, trial preparations, and regulatory development
Device manufacturing, trial preparations, and regulatory development
Device manufacturing, trial preparations, and regulatory development
Device manufacturing, trial preparations, and regulatory development
Device manufacturing, trial preparations, and regulatory development
Q4
Q4
Q4
Q4
Q4
Device biocompatibility
Device biocompatibility
Device biocompatibility
Device biocompatibility
Device biocompatibility
2022 Q1
2022 Q1
2022 Q1
2022 Q1
2022 Q1
TLA-005 Trial start
TLA-005 Trial start
TLA-005 Trial start
TLA-005 Trial start
TLA-005 Trial start
Q2
Q2
Q2
Q2
Q2
Q3
Q3
Q3
Q3
Q3
Q4
Q4
Q4
Q4
Q4
2023 Q1
2023 Q1
2023 Q1
2023 Q1
2023 Q1
TLA-003 Study report finalized
TLA-003 Study report finalized
TLA-003 Study report finalized
TLA-003 Study report finalized
TLA-003 Study report finalized
TLA-003 Trial end
TLA-003 Trial end
TLA-003 Trial end
TLA-003 Trial end
TLA-003 Trial end
TLA-004 Trial end
TLA-004 Trial end
TLA-004 Trial end
TLA-004 Trial end
TLA-004 Trial end
TLA-005 Trial end
TLA-005 Trial end
TLA-005 Trial end
TLA-005 Trial end
TLA-005 Trial end
TLA-002
TLA-003
TLA-004
TLA-005